Lv2
104 积分 2022-03-02 加入
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
2天前
已关闭
Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial
2天前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
2天前
已完结
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
8天前
已完结
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
1个月前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1个月前
已完结
The Microbiome and Cancer A Translational Science Review
1个月前
已关闭
The Microbiome and Cancer: A Translational Science Review
1个月前
已关闭
Small Cell Lung Cancer: A Review
1个月前
已完结
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
2个月前
已完结
皖公网安备34019202002308
